Coursera Spring Sale
40% Off Coursera Plus Annual!
Grab it
Learn about the groundbreaking case of Michael Roberts, believed to be the first British patient reimbursed by the NHS for medicinal cannabis flowers in cancer palliative care, through this 24-minute webinar presented by Dr. Guillermo Moreno-Sanz. Explore the clinical details of a rectosigmoid adenocarcinoma patient with lung metastases who experienced severe chemotherapy-induced nausea and vomiting (CINV) during FOLFIRI treatment, and discover how traditional antiemetics like metoclopramide, aprepitant, ondansetron, levomepromazine, and nabilone provided limited relief or caused intolerable side effects. Examine the patient's treatment journey through emergency Hartmann's procedure, second-line FOLFOX chemotherapy, and lung ablation, while analyzing how THC-predominant cannabis flower inhalation, when combined with standard medication, significantly improved not only CINV symptoms but also anxiety, sleep quality, appetite, overall mood, and quality of life. Understand the individual funding request (IFR) process that enabled NHS reimbursement and review patient-reported outcome measures collected through validated questionnaires at specialized private clinics. Gain insights into the potential pathway for other patients to access cannabis-based medicinal products through national healthcare services and consider the broader implications for integrating these treatments into standard oncology care. Access PACE credits through Labroots registration and completion requirements, with certification available until April 2027.
